Sol-Gel Technologies Ltd.
NASDAQ:SLGLBiotechnology
+$1.19 today
- Market cap
- $174.70M
- Beta
- 1.13
- P/E (TTM)
- -194.1
- EPS (TTM)
- -$0.37
Volume 0.03M
Average 0.04M
SLGL Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Sol-Gel Technologies Ltd.NASDAQ: SLGL
Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026
Other income / expenses declines year over year
Q1 FY2026 other income / expenses of $128K fell 51.0% year over year, behind the -3.8% change in trailing-twelve-month other income / expenses. Sequentially, it fell 69.8% from the prior quarter. Over 3 fiscal years it compounded at +2.2% a year.
Context
- Other income / expenses amounted to 7.3% of revenue in FY2025, down 5.2 pp from a year earlier.
- Other income / expenses increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -51.0% toward the trailing-twelve-month pace of -3.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- 1.41M USD
- Year-over-year change
- -1.6%
- 4-year CAGR
- +53.1%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.41M | -1.6% |
| FY2024 | 2024-12-31 | 1.43M | -30.6% |
| FY2023 | 2023-12-31 | 2.07M | +56.5% |
| FY2022 | 2022-12-31 | 1.32M | +414.0% |
| FY2021 | 2021-12-31 | 257K | — |
Other Income / Expenses vs competitors
How SLGL compares with its peers on the latest reported figures
- SLGL's LTM Mar 2026 other income / expenses of $1.28M is the 6th highest of the 10 companies compared; the peer median is $2.85M.
- Its year-over-year change of -3.8% is the 5th highest of 10, against a peer median of -26.4%.
- Other income / expenses amounts to 6.9% of revenue for SLGL, versus a peer median of 170.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $146.07M | +1533.0% | +213.5% | — | |
| LTM Mar 2026 | $23.57M | -26.4% | +162.8% | 330.9% | |
| LTM Mar 2026 | $21.47M | +277.4% | — | — | |
| LTM Mar 2026 | $5.99M | -61.1% | -42.7% | — | |
| FY2025 | $2.85M | +399.7% | — | — | |
| LTM Mar 2026 | $1.28M | -3.8% | +2.2% | 6.9% | |
| LTM Mar 2026 | $869.27K | -45.2% | — | 10.9% | |
| FY2025 | -$781.2K | +29.5% | — | — | |
| LTM Mar 2026 | -$7.37M | -116.5% | — | 4.7% | |
| LTM Mar 2026 | -$12.7M | -1019.6% | — | 9474.6% | |
| Peer median (excluding SLGL) | $2.85M | -26.4% | +162.8% | 170.9% | |
Competitors are the stored peer set for SLGL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 31.27M | 3.88M | 1.55M | 11.54M | 19.39M |
| Cost of Revenue | 20.38M | 12.68M | 342K | 233K | 109K |
| Gross Profit | 10.89M | (8.8M) | (21.99M) | 11.31M | 19.39M |
| Gross Margin | 34.8% | -226.6% | -1414.9% | 98.0% | 100.0% |
| Research & Development | 20.38M | 12.68M | 23.54M | 17.8M | 22.8M |
| Selling, General & Admin | 8.45M | 7.45M | 7.37M | 5.75M | 4.18M |
| Operating Expenses | 7.93M | 7.45M | 7.32M | 23.32M | 26.93M |
| Depreciation & Amortization | 880K | 562K | 342K | 233K | 109K |
| EBITDA | 3.84M | (15.68M) | (28.96M) | (10.35M) | (7.43M) |
| EBITDA Margin | 12.3% | -403.9% | -1863.8% | -89.7% | -38.3% |
| Operating Income | 2.96M | (16.24M) | (29.31M) | (12.01M) | (7.54M) |
| Operating Margin | 9.5% | -418.3% | -1885.8% | -104.1% | -38.9% |
| Interest Income | 257K | 1.32M | 2.07M | 1.43M | 1.41M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 257K | 1.32M | 2.07M | 1.43M | 1.41M |
| Income Before Tax | 3.22M | (14.92M) | (27.24M) | (10.58M) | (6.13M) |
| Pre-Tax Margin | 10.3% | -384.3% | -1752.8% | -91.7% | -31.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | 3.22M | (14.92M) | (27.24M) | (10.58M) | (6.13M) |
| Net Margin | 10.3% | -384.3% | -1752.8% | -91.7% | -31.6% |
| EPS (Basic) | 1.40 | (0.65) | (1.01) | (0.38) | (2.20) |
| EPS (Diluted) | 0.14 | (0.65) | (1.01) | (0.38) | (2.20) |
| Weighted Avg Shares | 23.06M | 23.13M | 27.09M | 27.86M | 2.79M |
| Weighted Avg Shares (Diluted) | 23.57M | 23.13M | 27.09M | 27.86M | 2.79M |
Sol-Gel Technologies Ltd.
NASDAQ:SLGL
Intrinsic Alpha fair value
Locked
Current Price
$53.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.